BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36889766)

  • 1. MiR-490-3p Sponged by lncRNA NEAT1 Can Attenuate Lung Adenocarcinoma Progression by Suppressing the RhoA/ROCK Signaling Pathway.
    Zhao L; Ren C; Fang Y; Li P; Zhang H; Zuo L; Zhang J; Zhao J
    Ann Clin Lab Sci; 2023 Jan; 53(1):42-51. PubMed ID: 36889766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PCAT6 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of lung adenocarcinoma cell by targeting miR-545-3p.
    Yang C; Huang H; Li Y; Zhuo T; Zhu L; Luo C; Wu Y; Qin S
    Mol Biol Rep; 2023 Apr; 50(4):3557-3568. PubMed ID: 36787056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA/ROCK signal pathway.
    Chen Y; Huang C; Duan ZB; Chen YX; Xu CY
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C292-C306. PubMed ID: 36440854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA RP11-89K21.1 Interacts with miR-146a/b-5p to Promote Proliferation and Gefitinib Resistance Through Regulating RHPN2 and RhoA/ROCK Pathway in Lung Adenocarcinoma.
    Chen H; Shen D; Zhu F; Ou Q; Cheng L; Zhu Y
    Cancer Biother Radiopharm; 2023 Jun; 38(5):282-292. PubMed ID: 33877886
    [No Abstract]   [Full Text] [Related]  

  • 9. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation of miR-345-5p suppresses cell growth of lung adenocarcinoma by regulating ras homolog family member A (RhoA) and Rho/Rho associated protein kinase (Rho/ROCK) pathway.
    Zhou QY; Gui SY; Zhang P; Wang M
    Chin Med J (Engl); 2021 Oct; 134(21):2619-2628. PubMed ID: 34748526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
    Qi L; Yin Y; Sun M
    Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
    Liu X; Yao W; Xiong H; Li Q; Li Y
    Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
    Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
    Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.
    Wang B; Cai Y; Li X; Kong Y; Fu H; Zhou J
    Cell Cycle; 2021 Dec; 20(24):2607-2618. PubMed ID: 34850664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway.
    Li B; Lu X; Ma C; Sun S; Shu X; Wang Z; Sun W
    Neurosci Lett; 2020 Jul; 732():135086. PubMed ID: 32454145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA LINC01006 Facilitates Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma via Targeting the MicroRNA 129-2-3p/CTNNB1 Axis and Activating Wnt/β-Catenin Signaling Pathway.
    Zhang Y; Liu H; Zhang Q; Zhang Z
    Mol Cell Biol; 2021 May; 41(6):e0038020. PubMed ID: 33753463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 promotes the progression of sepsis-induced myocardial cell injury by sponging miR-144-3p.
    Wei JL; Wu CJ; Chen JJ; Shang FT; Guo SG; Zhang XC; Liu H
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):851-861. PubMed ID: 32016991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.